Neuronetics, Inc. Stock-Based Compensation
Neuronetics, Inc. (STIM) reported Stock-Based Compensation of $2.37 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-11
- Neuronetics, Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $688.00K, a 62.07% decline year-over-year.
- Neuronetics, Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $1.68M, a 16.14% increase year-over-year.
- Neuronetics, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $2.18M, a 70.12% increase year-over-year.
- Neuronetics, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $1.41M, a 0.70% decline year-over-year.
- Neuronetics, Inc. share-based payment arrangement, noncash expense for fiscal 2025 was $6.85M, a 22.24% increase from fiscal 2024.
- Neuronetics, Inc. share-based payment arrangement, noncash expense for fiscal 2024 was $5.60M, a 23.46% decline from fiscal 2023.
- Neuronetics, Inc. share-based payment arrangement, noncash expense for fiscal 2023 was $7.32M, a 16.32% decline from fiscal 2022.
- Neuronetics, Inc. share-based payment arrangement, noncash expense for fiscal 2022 was $8.75M, a 11.14% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 9 month as first filed | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $688.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $2.37M 10-Q · filed 2026-08-11 | $4.55M derived: sum of 3 quarters · filed 2026-08-11 | $5.96M derived: sum of 4 quarters · filed 2026-08-11 | |
| 2026-03-31 | $1.68M 10-Q · filed 2026-05-05 | $3.86M derived: sum of 2 quarters · filed 2026-05-05 | $5.27M derived: sum of 3 quarters · filed 2026-05-05 | $7.08M derived: sum of 4 quarters · filed 2026-08-11 | |
| 2025-12-31 | $2.18M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | $3.59M derived: sum of 2 quarters · filed 2026-03-17 | $5.40M derived: sum of 3 quarters · filed 2026-08-11 | $6.85M 10-K · filed 2026-03-17 | |
| 2025-09-30 | $1.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $3.22M derived: sum of 2 quarters · filed 2026-08-11 | $4.67M 10-Q · filed 2025-11-04 | $5.95M derived: sum of 4 quarters · filed 2026-08-11 | |
| 2025-06-30 | $1.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $3.26M 10-Q · filed 2026-08-11 | $4.54M derived: sum of 3 quarters · filed 2026-08-11 | $5.96M derived: sum of 4 quarters · filed 2026-08-11 | |
| 2025-03-31 | $1.44M 10-Q · filed 2026-05-05 | $2.73M derived: sum of 2 quarters · filed 2026-05-05 | $4.14M derived: sum of 3 quarters · filed 2026-05-05 | $5.71M derived: sum of 4 quarters · filed 2026-05-05 | |
| 2024-12-31 | $1.28M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | $2.70M derived: sum of 2 quarters · filed 2026-03-17 | $4.26M derived: sum of 3 quarters · filed 2026-03-17 | $5.60M 10-K · filed 2026-03-17 | |
| 2024-09-30 | $1.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $2.98M derived: sum of 2 quarters · filed 2025-11-04 | $4.32M 10-Q · filed 2025-11-04 | $11.05M derived: sum of 4 quarters · filed 2026-03-17 | |
| 2024-06-30 | $1.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $2.90M 10-Q · filed 2025-08-05 | $9.63M derived: sum of 3 quarters · filed 2026-03-17 | $6.38M derived: sum of 4 quarters · filed 2026-03-17 | |
| 2024-03-31 | $1.34M 10-Q · filed 2025-05-06 | $8.07M derived: sum of 2 quarters · filed 2026-03-17 | $4.82M derived: sum of 3 quarters · filed 2026-03-17 | $6.85M derived: sum of 4 quarters · filed 2026-03-17 | |
| 2023-12-31 | $6.73M derived: 10-K 12 month − 8-K/A 9 month · filed 2026-03-17 | $3.48M derived: sum of 2 quarters · filed 2026-03-17 | $5.51M derived: sum of 3 quarters · filed 2026-03-17 | $7.32M 10-K · filed 2026-03-17 | |
| 2023-09-30 | -$3.25M derived: 8-K/A 9 month − 10-Q 6 month · filed 2025-02-06 | -$1.21M derived: sum of 2 quarters · filed 2025-02-06 | $591.47K 8-K/A · filed 2025-02-06 | $5.69M 10-Q · filed 2023-11-07 | $2.70M derived: sum of 4 quarters · filed 2025-03-27 |
| 2023-06-30 | $2.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $3.84M 10-Q · filed 2024-08-12 | $5.95M derived: sum of 3 quarters · filed 2025-03-27 | $8.13M derived: sum of 4 quarters · filed 2025-03-27 | |
| 2023-03-31 | $1.80M 10-Q · filed 2024-05-07 | $3.92M derived: sum of 2 quarters · filed 2025-03-27 | $6.10M derived: sum of 3 quarters · filed 2025-03-27 | $8.30M derived: sum of 4 quarters · filed 2025-03-27 | |
| 2022-12-31 | $2.11M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $4.29M derived: sum of 2 quarters · filed 2025-03-27 | $6.49M derived: sum of 3 quarters · filed 2025-03-27 | $8.75M 10-K · filed 2025-03-27 | |
| 2022-09-30 | $2.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $4.38M derived: sum of 2 quarters · filed 2023-11-07 | $6.63M 10-Q · filed 2023-11-07 | $8.34M derived: sum of 4 quarters · filed 2024-03-08 | |
| 2022-06-30 | $2.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $4.46M 10-Q · filed 2023-08-08 | $6.16M derived: sum of 3 quarters · filed 2024-03-08 | $8.12M derived: sum of 4 quarters · filed 2024-03-08 | |
| 2022-03-31 | $2.25M 10-Q · filed 2023-05-15 | $3.96M derived: sum of 2 quarters · filed 2024-03-08 | $5.92M derived: sum of 3 quarters · filed 2024-03-08 | $7.92M derived: sum of 4 quarters · filed 2024-03-08 | |
| 2021-12-31 | $1.70M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08 | $3.66M derived: sum of 2 quarters · filed 2024-03-08 | $5.67M derived: sum of 3 quarters · filed 2024-03-08 | $7.87M 10-K · filed 2024-03-08 | |
| 2021-09-30 | $1.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $3.97M derived: sum of 2 quarters · filed 2022-11-08 | $6.17M 10-Q · filed 2022-11-08 | $7.68M derived: sum of 4 quarters · filed 2023-03-07 | |
| 2021-06-30 | $2.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | $4.21M 10-Q · filed 2022-08-02 | $5.72M derived: sum of 3 quarters · filed 2023-03-07 | $6.77M derived: sum of 4 quarters · filed 2023-03-07 | |
| 2021-03-31 | $2.20M 10-Q · filed 2022-05-12 | $3.71M derived: sum of 2 quarters · filed 2023-03-07 | $4.76M derived: sum of 3 quarters · filed 2023-03-07 | $5.40M derived: sum of 4 quarters · filed 2023-03-07 | |
| 2020-12-31 | $1.52M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-07 | $2.56M derived: sum of 2 quarters · filed 2023-03-07 | $3.21M derived: sum of 3 quarters · filed 2023-03-07 | $4.40M 10-K · filed 2023-03-07 | |
| 2020-09-30 | $1.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $1.69M derived: sum of 2 quarters · filed 2021-11-09 | $2.89M 10-Q · filed 2021-11-09 | $3.86M derived: sum of 4 quarters · filed 2022-03-08 | |
| 2020-06-30 | $646.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | $1.84M 10-Q · filed 2021-08-03 | $2.82M derived: sum of 3 quarters · filed 2022-03-08 | $3.75M derived: sum of 4 quarters · filed 2022-03-08 | |
| 2020-03-31 | $1.20M 10-Q · filed 2021-05-04 | $2.17M derived: sum of 2 quarters · filed 2022-03-08 | $3.11M derived: sum of 3 quarters · filed 2022-03-08 | $4.13M derived: sum of 4 quarters · filed 2022-03-08 | |
| 2019-12-31 | $976.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | $1.91M derived: sum of 2 quarters · filed 2022-03-08 | $2.93M derived: sum of 3 quarters · filed 2022-03-08 | $3.43M 10-K · filed 2022-03-08 | |
| 2019-09-30 | $935.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-02 | $1.96M derived: sum of 2 quarters · filed 2020-11-02 | $2.46M 10-Q · filed 2020-11-02 | $2.84M derived: sum of 4 quarters · filed 2021-03-02 | |
| 2019-06-30 | $1.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | $1.52M 10-Q · filed 2020-08-04 | $1.90M derived: sum of 3 quarters · filed 2021-03-02 | $2.93M derived: sum of 4 quarters · filed 2021-03-02 | |
| 2019-03-31 | $501.00K 10-Q · filed 2020-05-05 | $880.00K derived: sum of 2 quarters · filed 2021-03-02 | $1.91M derived: sum of 3 quarters · filed 2021-03-02 | $2.10M derived: sum of 4 quarters · filed 2021-03-02 | |
| 2018-12-31 | $379.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-02 | $1.41M derived: sum of 2 quarters · filed 2021-03-02 | $1.60M derived: sum of 3 quarters · filed 2021-03-02 | $1.74M 10-K · filed 2021-03-02 | |
| 2018-09-30 | $1.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $1.22M derived: sum of 2 quarters · filed 2019-11-05 | $1.36M 10-Q · filed 2019-11-05 | $1.56M derived: sum of 4 quarters · filed 2020-03-03 | |
| 2018-06-30 | $192.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $336.00K 10-Q · filed 2019-08-06 | $537.00K derived: sum of 3 quarters · filed 2020-03-03 | $634.00K derived: sum of 4 quarters · filed 2020-03-03 | |
| 2018-03-31 | $144.00K 10-Q · filed 2019-05-07 | $345.00K derived: sum of 2 quarters · filed 2020-03-03 | $442.00K derived: sum of 3 quarters · filed 2020-03-03 | ||
| 2017-12-31 | $201.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-03 | $298.00K derived: sum of 2 quarters · filed 2020-03-03 | $496.00K 10-K · filed 2020-03-03 | ||
| 2017-09-30 | $97.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $295.00K 10-Q · filed 2018-11-06 | |||
| 2017-06-30 | $198.00K 10-Q · filed 2018-08-14 | ||||
| 2016-12-31 | $161.00K 10-K · filed 2019-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |